Clinical and molecular analysis of spinal muscular atrophy in Brazilian patients
Spinal muscular atrophy (SMA), the second most common lethal autosomal recessive disorder, has an incidence of 1:10,000 newborns. SMA is divided into acute (Werdnig-Hoffmann disease, type I), intermediate (type II) and juvenile forms (Kugelberg-Welander disease, type III). The gene of all three form...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Genética
1999-12-01
|
Series: | Genetics and Molecular Biology |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47571999000400005 |
id |
doaj-a98169b04cc04b70ad4ec54e8452232e |
---|---|
record_format |
Article |
spelling |
doaj-a98169b04cc04b70ad4ec54e8452232e2020-11-24T21:56:57ZengSociedade Brasileira de GenéticaGenetics and Molecular Biology1415-47571678-46851999-12-0122448749210.1590/S1415-47571999000400005Clinical and molecular analysis of spinal muscular atrophy in Brazilian patientsC.A. KimM.R. Passos-BuenoS.K. MarieA. CerqueiraU. ContiM.J. Marques-DiasC.H. GonzalezM. ZatzSpinal muscular atrophy (SMA), the second most common lethal autosomal recessive disorder, has an incidence of 1:10,000 newborns. SMA is divided into acute (Werdnig-Hoffmann disease, type I), intermediate (type II) and juvenile forms (Kugelberg-Welander disease, type III). The gene of all three forms of SMA maps to chromosome 5q 11.2-13.3. Two candidate genes, the survival motor neuron (SMN) gene and the neuronal apoptosis inhibitory protein (NAIP) gene, have been identified; SMN is deleted in most SMA patients. We studied both genes in 87 Brazilian SMA patients (20 type I, 14 type II and 53 type III) from 74 unrelated families, by using PCR and single strand conformation polymorphism (SSCP). Deletions of exons 7 and/or 8 of the SMN gene were found in 69% of the families: 16/20 in type I, 9/12 in type II and 26/42 in type III. Among 51 families with deletions, 44 had both exons deleted while seven had deletions only of exon 7. Deletions of exon 5 of the NAIP gene were found in 7/20 of type I, 2/12 of type II and 1/42 of type III patients. No deletion of SMN and NAIP genes was found in 112 parents, 26 unaffected sibs and 104 normal controls. No correlation between deletions of one or both genes and phenotype severity was found.<br>As amiotrofias espinhais progressivas (SMAs) constituem as doenças degenerativas de origem genética letais mais comuns do sistema nervoso central e mais freqüentes dentre as doenças autossômicas recessivas após a mucoviscidose. A incidência estimada das SMAs é de aproximadamente 1:10.000 nativivos. Clinicamente, as SMAs são classificadas em mais grave (doença de Werdnig-Hoffmann, tipo I), intermediária (tipo II) e tardia e benigna (doença de Kugelberg-Welander, tipo III). O gene para os três tipos de SMAs foi mapeado no cromossomo 5 q11.2-13.3. Foram identificados dois genes candidatos na mesma região: SMN (sobrevida do neurônio motor) e NAIP (proteína inibidora de apoptose neuronal). Estudamos ambos genes em 87 pacientes brasileiros (20 tipo I,14 tipo II e 53 tipo III) pertencentes a 74 famílias, utilizando as técnicas de PCR e SSCP. Foi encontrada deleção nos exons 7 e/ou 8 do gene SMN em 69% das famílias: 16/20 na tipo I, 9/12 na tipo II e 26/42 na tipo III. Dentre as 51 famílias com deleção, 44 tiveram deleção nos exons 7 e 8 enquanto 7 tiveram deleção somente no exon 7. Deleção no exon 5 do gene NAIP foi encontrada em 7/20 na tipo I, 2/12 na tipo II e 1/42 na tipo III. Não foi encontrada deleção nos genes SMN e NAIP nos 112 progenitores, 26 irmandades assintomáticas e 104 controles normais. Não houve correlação entre deleção de um ou ambos genes com a gravidade do quadro clínico.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47571999000400005 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
C.A. Kim M.R. Passos-Bueno S.K. Marie A. Cerqueira U. Conti M.J. Marques-Dias C.H. Gonzalez M. Zatz |
spellingShingle |
C.A. Kim M.R. Passos-Bueno S.K. Marie A. Cerqueira U. Conti M.J. Marques-Dias C.H. Gonzalez M. Zatz Clinical and molecular analysis of spinal muscular atrophy in Brazilian patients Genetics and Molecular Biology |
author_facet |
C.A. Kim M.R. Passos-Bueno S.K. Marie A. Cerqueira U. Conti M.J. Marques-Dias C.H. Gonzalez M. Zatz |
author_sort |
C.A. Kim |
title |
Clinical and molecular analysis of spinal muscular atrophy in Brazilian patients |
title_short |
Clinical and molecular analysis of spinal muscular atrophy in Brazilian patients |
title_full |
Clinical and molecular analysis of spinal muscular atrophy in Brazilian patients |
title_fullStr |
Clinical and molecular analysis of spinal muscular atrophy in Brazilian patients |
title_full_unstemmed |
Clinical and molecular analysis of spinal muscular atrophy in Brazilian patients |
title_sort |
clinical and molecular analysis of spinal muscular atrophy in brazilian patients |
publisher |
Sociedade Brasileira de Genética |
series |
Genetics and Molecular Biology |
issn |
1415-4757 1678-4685 |
publishDate |
1999-12-01 |
description |
Spinal muscular atrophy (SMA), the second most common lethal autosomal recessive disorder, has an incidence of 1:10,000 newborns. SMA is divided into acute (Werdnig-Hoffmann disease, type I), intermediate (type II) and juvenile forms (Kugelberg-Welander disease, type III). The gene of all three forms of SMA maps to chromosome 5q 11.2-13.3. Two candidate genes, the survival motor neuron (SMN) gene and the neuronal apoptosis inhibitory protein (NAIP) gene, have been identified; SMN is deleted in most SMA patients. We studied both genes in 87 Brazilian SMA patients (20 type I, 14 type II and 53 type III) from 74 unrelated families, by using PCR and single strand conformation polymorphism (SSCP). Deletions of exons 7 and/or 8 of the SMN gene were found in 69% of the families: 16/20 in type I, 9/12 in type II and 26/42 in type III. Among 51 families with deletions, 44 had both exons deleted while seven had deletions only of exon 7. Deletions of exon 5 of the NAIP gene were found in 7/20 of type I, 2/12 of type II and 1/42 of type III patients. No deletion of SMN and NAIP genes was found in 112 parents, 26 unaffected sibs and 104 normal controls. No correlation between deletions of one or both genes and phenotype severity was found.<br>As amiotrofias espinhais progressivas (SMAs) constituem as doenças degenerativas de origem genética letais mais comuns do sistema nervoso central e mais freqüentes dentre as doenças autossômicas recessivas após a mucoviscidose. A incidência estimada das SMAs é de aproximadamente 1:10.000 nativivos. Clinicamente, as SMAs são classificadas em mais grave (doença de Werdnig-Hoffmann, tipo I), intermediária (tipo II) e tardia e benigna (doença de Kugelberg-Welander, tipo III). O gene para os três tipos de SMAs foi mapeado no cromossomo 5 q11.2-13.3. Foram identificados dois genes candidatos na mesma região: SMN (sobrevida do neurônio motor) e NAIP (proteína inibidora de apoptose neuronal). Estudamos ambos genes em 87 pacientes brasileiros (20 tipo I,14 tipo II e 53 tipo III) pertencentes a 74 famílias, utilizando as técnicas de PCR e SSCP. Foi encontrada deleção nos exons 7 e/ou 8 do gene SMN em 69% das famílias: 16/20 na tipo I, 9/12 na tipo II e 26/42 na tipo III. Dentre as 51 famílias com deleção, 44 tiveram deleção nos exons 7 e 8 enquanto 7 tiveram deleção somente no exon 7. Deleção no exon 5 do gene NAIP foi encontrada em 7/20 na tipo I, 2/12 na tipo II e 1/42 na tipo III. Não foi encontrada deleção nos genes SMN e NAIP nos 112 progenitores, 26 irmandades assintomáticas e 104 controles normais. Não houve correlação entre deleção de um ou ambos genes com a gravidade do quadro clínico. |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47571999000400005 |
work_keys_str_mv |
AT cakim clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients AT mrpassosbueno clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients AT skmarie clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients AT acerqueira clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients AT uconti clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients AT mjmarquesdias clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients AT chgonzalez clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients AT mzatz clinicalandmolecularanalysisofspinalmuscularatrophyinbrazilianpatients |
_version_ |
1725856179373998080 |